Nauck MA, Meier JJ (2019) Are all GLP-1 agonists equal in the treatment of type 2 diabetes
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
The community standard isn't a single ratio
10 Our gut produces around 95% of our bodys serotonin, a neurotransmitter closely linked to mood and anxiety
Many people experience weight regain after stopping the medication, especially if metabolic, hormonal, or lifestyle factors remain unaddressed
found that GLP-1RA medications may have broader heart and metabolic effects, as well as reduce inflammation in addition to weight loss and glucose control in high-risk populations
